{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's research and improve coordination among National Institutes of Health research institutes. It also seeks to enhance care and assistance for individuals with Parkinson's and their family caregivers. The Director of NIH will establish a program for Parkinson's disease research and training, subject to available funds. Coordination among national research institutes conducting Parkinson's research will be ensured through regular conferences. The Director of NIH will award Core Center Grants to establish Morris K. Udall Research Centers for Parkinson's disease research and training. Each center funded under these grants will focus on innovative multidisciplinary research on Parkinson's. The Director of NIH awards Core Center Grants to establish Morris K. Udall Research Centers for Parkinson's disease research and training. Each center must be an institution or consortium meeting NIH qualifications and conduct basic and clinical research. Centers may also offer training programs, information for health professionals, and public education programs. The NIH awards Core Center Grants to establish Morris K. Udall Research Centers for Parkinson's disease research and training. These centers aim to establish a nationwide data system, a Parkinson's Disease Information Clearinghouse, and a national education program to enhance knowledge and understanding of Parkinson's disease. The NIH awards Core Center Grants to establish Morris K. Udall Research Centers for Parkinson's disease research and training. These centers may provide stipends for scientists and health professionals in training programs and receive support for up to five years, extendable for additional periods upon review. Additionally, the Director of NIH will establish a grant program for excellence in Parkinson's Disease research. The Director of NIH will establish a grant program to support excellence in Parkinson's research, with grants available for up to 5 years. $100,000,000 is authorized for fiscal year 1998, with additional funding for 1999 and 2000. No funds can be used for research involving human fetal tissue. The subsection prohibits the use of human fetal tissue for Parkinson's research, except for tissue obtained from spontaneous abortions or ectopic pregnancies."
}